Indian Patent Dispute Settlement Panel Set Up

9 December 1996

India has agreed to the formation of a dispute settlement panel, following a complaint to the World Trade Organization from the USA, according to the Marketletter's local correspondent.

The USA complained that India had failed to implement its obligations under the agreement on Trade Related Aspects of Intellectual Property Rights (TRIPs). At talks in Geneva, Switzerland, India's chief negotiator, Mr S Narayanan, acquiesced to the US call.

With this agreement, India may have to introduce the Patents Amendments Bill in Parliament before the winter session comes to a close, just prior to Christmas. The matter has also been under considerable discussion and debate at the recent meeting in New Delhi on intellectual property rights (see also pages 26 and 27 and Marketletter November 25).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight